Autoimmune biomarkers in porto‐sinusoidal vascular disease: Potential role in its diagnosis and pathophysiology

Porto‐sinusoidal vascular disease (PSVD) is a rare disease that requires excluding cirrhosis and other causes of portal hypertension for its diagnosis because it lacks a specific diagnostical test. Although it has been occasionally associated with autoimmune diseases, the pathophysiology of PSVD remains unknown. The aim of this study was to evaluate the potential role of autoimmunity in the pathophysiology and diagnosis of PSVD.

[1]  J. Neuberger,et al.  Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology , 2020, Gut.

[2]  V. Vilgrain,et al.  Porto-sinusoidal vascular disease: proposal and description of a novel entity. , 2019, The lancet. Gastroenterology & hepatology.

[3]  J. Verheij,et al.  Idiopathic non-cirrhotic portal hypertension: a review , 2015, Orphanet Journal of Rare Diseases.

[4]  E. Elias,et al.  Idiopathic Non-Cirrhotic Intrahepatic Portal Hypertension (NCIPH)-Newer Insights into Pathogenesis and Emerging Newer Treatment Options. , 2014, Journal of clinical and experimental hepatology.

[5]  A. Berzigotti,et al.  Idiopathic portal hypertension: Natural history and long‐term outcome , 2014, Hepatology.

[6]  F. Bucchieri,et al.  Elevated blood Hsp60, its structural similarities and cross-reactivity with thyroid molecules, and its presence on the plasma membrane of oncocytes point to the chaperonin as an immunopathogenic factor in Hashimoto's thyroiditis , 2014, Cell Stress and Chaperones.

[7]  K. Abe,et al.  Case of idiopathic portal hypertension complicated with autoimmune hepatitis , 2013, Hepatology research : the official journal of the Japan Society of Hepatology.

[8]  M. Honda,et al.  Induction of elastin expression in vascular endothelial cells relates to hepatoportal sclerosis in idiopathic portal hypertension: possible link to serum anti‐endothelial cell antibodies , 2012, Clinical and experimental immunology.

[9]  D. Valla,et al.  Idiopathic noncirrhotic portal hypertension , 2011, Hepatology.

[10]  G. Mieli-Vergani,et al.  Autoimmune hepatitis. , 2011, Journal of hepatology.

[11]  O. Cummings,et al.  Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network , 2011, Hepatology International.

[12]  A. Pshezhetsky,et al.  Caspase-3-mediated secretion of connective tissue growth factor by apoptotic endothelial cells promotes fibrosis , 2010, Cell Death and Differentiation.

[13]  J. Tervaert,et al.  Anti-endothelial cell antibodies in systemic sclerosis , 2010, Annals of the rheumatic diseases.

[14]  J. Blanco,et al.  Idiopathic Portal Hypertension in Patients With HIV Infection Treated With Highly Active Antiretroviral Therapy , 2009, The American Journal of Gastroenterology.

[15]  T. Usa,et al.  Prevalence of interrelated autoantibodies in thyroid diseases and autoimmune disorders , 2008, Journal of endocrinological investigation.

[16]  S. Kaveri,et al.  Natural anti-endothelial cell antibodies. , 2008, Autoimmunity reviews.

[17]  S. Kaveri,et al.  Identification of target antigens of antiendothelial cell antibodies in healthy individuals: A proteomic approach , 2008, Proteomics.

[18]  L. Mouthon,et al.  Antiendothelial Cells Autoantibodies in Vasculitis-Associated Systemic Diseases , 2008, Clinical reviews in allergy & immunology.

[19]  R. Battikh,et al.  Hypertension portale idiopathique associée à une maladie cœliaque : à propos d’un cas , 2007 .

[20]  Y. Chawla,et al.  Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment , 2007, Hepatology international.

[21]  Y. Lou,et al.  Flavonoids From Seabuckthorn Protect Endothelial Cells (EA.hy926) From Oxidized Low-density Lipoprotein Induced Injuries Via Regulation of LOX-1 and eNOS Expression , 2006, Journal of cardiovascular pharmacology.

[22]  R. Nada,et al.  Association of celiac disease with non‐cirrhotic portal fibrosis , 2006, Journal of gastroenterology and hepatology.

[23]  S. Verma,et al.  Factors Predicting Relapse and Poor Outcome in Type I Autoimmune Hepatitis: Role of Cirrhosis Development, Patterns of Transaminases During Remission and Plasma Cell Activity in the Liver Biopsy , 2004, American Journal of Gastroenterology.

[24]  Y. Shoenfeld,et al.  Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications. , 2002, Arthritis and rheumatism.

[25]  C. Ponticelli,et al.  Anti-endothelial cell IgG fractions from systemic lupus erythematosus patients bind to human endothelial cells and induce a pro-adhesive and a pro-infiammatory phenotype in vitro , 1999, Lupus.

[26]  K. Tokushige,et al.  Analysis of adhesion molecules in patients with idiopathic portal hypertension , 1999, Journal of gastroenterology and hepatology.

[27]  S. Motoyama,et al.  Hydrogen peroxide derived from hepatocytes induces sinusoidal endothelial cell apoptosis in perfused hypoxic rat liver. , 1998, Gastroenterology.

[28]  T. Mizuguchi,et al.  Heat shock protein 70 messenger RNA reflects the severity of ischemia/hypoxia-reperfusion injury in the perfused rat liver. , 1997, Critical care medicine.

[29]  F. Lottspeich,et al.  Identification of stress proteins in endothelial cells , 1996, Electrophoresis.

[30]  A. J. Gandolfi,et al.  Sodium arsenite and heat shock induce stress proteins in precision-cut rat liver slices. , 1995, Toxicology.

[31]  Y. Nakanuma,et al.  Non-specific immunological abnormalities and association of autoimmune diseases in idiopathic portal hypertension. A study by questionnaire. , 1993, Hepato-gastroenterology.

[32]  K. Kawai,et al.  Use of Patients' Sera for Immunoperoxidase Demonstration of Infectious Agents in Paraffin Sections , 1991, Acta pathologica japonica.

[33]  T. Terada,et al.  Expression of HLA-DR antigen on hepatic vascular endothelial cells in idiopathic portal hypertension. , 1991, Clinical and experimental immunology.

[34]  S. Borkan,et al.  Transient ischemia or heat stress induces a cytoprotectant protein in rat kidney. , 1991, The American journal of physiology.

[35]  L. Schiaffonati,et al.  Synthesis of heat shock proteins in rat liver after ischemia and hyperthermia , 1985, Hepatology.